Recently, Abdelmageed et al. illustrated that PCA improved hepatic insulin resistance by modulating the insulin receptor substrate 1/phosphoinositide-3-kinase/Akt2 (IRS1/PI3K/Akt2) pathway [17]. The gene discussed is AKT2; the disease is Insulin resistance.